Interferon-gamma and interleukin-6 augment the human in vitro antibody response to the Haemophilus influenzae type-b polysaccharide
Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease
Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in the Netherlands
Three years of surveillance of invasive infections by Haemophilus influenzae after introduction of immunisation in the National Immunisation Programme
Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries